Treatment of severe acute respiratory syndrome with convalescent plasma

Hong Kong Medical Journal

Volumn 9, Issue 3, 2003, Pages 199-201

  Wong, V W S ^a   Dai, D ^a   Wu, A K L ^a   Sung, J J Y ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Fever; Pneumonia; Ribavirin; Severe acute respiratory syndrome

Indexed keywords

AMINOTRANSFERASE; CEFOTAXIME; CORTICOSTEROID; LEVOFLOXACIN; METHYLPREDNISOLONE; OSELTAMIVIR; PREDNISOLONE; RIBAVIRIN;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CASE REPORT; COUGHING; DISEASE COURSE; FEMALE; FEVER; HONG KONG; HUMAN; LYMPHOCYTOPENIA; MALAISE; PLASMA TRANSFUSION; PNEUMONIA; SEVERE ACUTE RESPIRATORY SYNDROME;

CONVALESCENCE; FEMALE; HUMANS; IMMUNOTHERAPY; MIDDLE AGED; PLASMA; SEVERE ACUTE RESPIRATORY SYNDROME;

EID: 0038690593     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Outbreak of severe acute respiratory syndrome - worldwide, 2003. MMWR Morb Mortal Wkly Rep 2003;52:226-8.
2. Poutanen SM, Low DE, Henry B, et al. Identification of severe acute respiratory syndrome in Canada. N Engl J Med. In press 2003.
3. Tsang KW, Ho PL, Ooi GC, et al. A cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med. In press 2003.
4. Graci JD, Cameron CE. Quasispecies, error catastrophe, and the antiviral activity of ribavirin. Virology 2002;298:175-80.
5. Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. The PREVENT Study Group. Pediatrics 1997;99:93-9.